Primary metastatic prostate cancer between prognosis or adequate/proper medical therapy

PURPOSE: To define the efficacy of standard androgen deprivation therapy (ADT) in the treatment of metastatic prostate cancer (PCa). MATERIALS AND METHODS: Fifty patients with mean age of 70.48 ± 9.95 years old (range 52–87) who had metastatic PCa and received ADT between 2014 and 2019 were retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Mahmoud, Rass, Honood Abu, Yahya, Mothafr, Hamdan, Khaleel, Eiss, Yazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783967/
https://www.ncbi.nlm.nih.gov/pubmed/33397422
http://dx.doi.org/10.1186/s12957-020-02111-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783967/
https://www.ncbi.nlm.nih.gov/pubmed/33397422
http://dx.doi.org/10.1186/s12957-020-02111-3

Ejemplares similares